Learn more about whether Haemonetics Corporation or LeMaitre Vascular, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Lantheus Holdings, Inc. or QuidelOrtho Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Fulcrum Therapeutics' promising treatment for Sickle Cell Disease and their strong financial position, despite setbacks.

JMP Securities reiterated its Market Outperform rating on Protagonist Therapeutics (NASDAQ:PTGX) with a steady price target ...

Haemonetics Corporation HAE delivered third-quarter fiscal 2025 adjusted earnings per share (EPS) of $1.19, which rose 14.4% ...

We recently published a list of 10 Firms Hit Hard in Thursday’s Trading. In this article, we are going to take a look at ...

Correlation, of course, is not causation. But even skeptical market strategists acknowledge that when a team from Philadelphia wins the Super ...

Worries about tariffs, artificial intelligence and big-cap tech haven't been able to keep U.S. stocks from climbing back to the doorstep of record territory. While Friday's jobs report for January was ...

Here is how the Barron’s Roundtable members’ picks performed. Find investment ideas for your portfolio with the latest stock picks from Barron’s below. These picks are the product of the ...

Nicaragua's economy will likely grow at around 4% this year, similar to its expected 2024 expansion, due to prudent macro-economic polices as well as "high" remittances, according to a Friday ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

However, deposit rates adjustments might lag. He highlights the importance of market liquidity and other measures announced by RBI to support economic growth and address short-term liquidity concerns.